Walt Disney announced that its Disneyland Paris theme park won't be reopened on Feb. 13 as had been planned due to the resurgence in COVID-19 cases
Goldman Smashes Revenue, Profit Expectations As Loss Provisions Slide
Small-cap stocks have taken a back seat to large caps in recent years, but the relative drought is over. Or at least it’s faded in recent...
Logitech shares are up more than 5% after revising its results upwards for 2021. It expects growth in sales of between 57% and 60%.
Should you avoid every stock that has shown enormous growth in recent months? Or should you ignore it, and focus on the fast-appreciating equities?
Quest Diagnostics has inked an agreement with the US Centers for Disease Control and Prevention (CDC) to provide genomic sequencing to identify new mutations and patterns...
Social media giants Facebook and Twitter sparked debates after they banned Donald Trump on their platforms following the US Capitol attack.
Palantir Technologies will likely lose its contract with the US federal government to develop the COVID-19 tracker system
Public health authorities in California are seeking a halt on dosing of one lot of Moderna’s COVID-19 vaccine.
Three major hurdles to Joe Biden;s sweeping proposal for $1.9 trillion more in COVID-19 relief package and stimulus spending
These 3 "Strong Buy" Stocks Are Top Picks for 2021, Say Analysts...
SkyWest Airlines will receive $233 million in PPP Loans to help it pay for the wages and other benefits of thousands of SkyWest Airlines employees.
Airbnb CEO Brian Chesky told Reuters that domestic travel trends will never be going back to the way it was before the virus pandemic.
80% Of SMB Owners Need PPP Funding ASAP, But 58% Say Expedited Vaccine Distribution Is Even More Crucial
This market is reminiscent of the days leading up to Christmas Eve 2018. For those who don’t remember, it was a pretty dark day for those...
The markets are trading in the red due to doubts generated by doubts of the Biden economic plan. Will they close the week negative?
Pfizer Announces COVID-19 Vaccines Shipment Delays
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
Chip Stocks Soar To Record After Taiwan Semi Unveils $28BN Spending Blitz
South Korea’s Celltrion has announced encouraging top-line results for its potential antibody therapy for COVID-19, with the first The post Celltrion closes in on COVID-19 antibody...
Bitcoin (BTC) surged higher on Jan. 14, reaching $40,000 amid fresh evidence of new large buys on exchanges.
Trade War? China’s pandemic-driven export boom continued into December, pushing China's trade surplus to a record high in the last month of 2020
Stocks, Yields Rise On Expectations Of "Biden's Trillions"
Vaccine Stocks and the emergence of a vaccine glut
UK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalize COVID-19 patients
J& J is on track to roll out a single-shot coronavirus vaccine in March, and plans to have clear data on how effective it is by...
Why Nvidia Is My “Slam Dunk” Investment for the Decade by Stephen McBride What was the most important financial event of 2020? Most folks would tell...
Boeing Co.’s aircraft deliveries more than halved last year as the coronavirus pandemic brought air travel demand to an almost complete halt.
U.S. firm Johnson & Johnson is likely to apply for EU approval for the company's Covid-19 vaccine candidate in February, a top lawmaker said.
China’s Sinovac Biotech defended the safety and efficacy of their Covid-19 vaccine, after researchers in Brazil released results showing efficacy that was much lower